ARGENX SE Research and Development Expense
ARGENX SE (ARGX) reported Research and Development Expense of $1.36 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-19
EUR
| Period end | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|
| 2020-12-31 | 325.48M EUR 20-F · filed 2021-03-30 | |
| 2020-06-30 | 171.72M EUR 6-K · filed 2020-07-31 | |
| 2019-12-31 | 197.66M EUR 20-F · filed 2021-03-30 | |
| 2019-06-30 | 78.30M EUR 6-K · filed 2020-07-31 | |
| 2018-12-31 | 83.61M EUR 20-F · filed 2021-03-30 | |
| 2018-06-30 | 34.37M EUR 6-K · filed 2019-08-01 | |
| 2017-12-31 | 51.74M EUR 20-F · filed 2020-03-31 | |
| 2017-06-30 | 25.59M EUR 6-K · filed 2018-08-02 | |
| 2016-12-31 | 31.56M EUR 20-F · filed 2019-03-26 | |
| 2015-12-31 | 20.64M EUR 20-F · filed 2018-03-26 |
USD
| Period end | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $1.36B 20-F · filed 2026-03-19 | |
| 2025-06-30 | $636.77M 6-K · filed 2025-07-31 | |
| 2024-12-31 | $983.42M 20-F · filed 2026-03-19 | |
| 2024-06-30 | $450.25M 6-K · filed 2025-07-31 | |
| 2023-12-31 | $859.49M 20-F · filed 2026-03-19 | |
| 2023-06-30 | $361.36M 6-K · filed 2024-07-25 | |
| 2022-12-31 | $663.37M 20-F · filed 2025-03-20 | |
| 2022-06-30 | $278.89M 6-K · filed 2023-07-27 | |
| 2021-12-31 | $580.52M 20-F · filed 2024-03-21 | |
| 2021-06-30 | $273.91M 6-K · filed 2022-07-28 | |
| 2020-12-31 | $370.88M 20-F · filed 2023-03-16 | |
| 2020-06-30 | $189.25M 6-K · filed 2021-07-29 | |
| 2019-12-31 | $220.77M 20-F · filed 2022-03-21 | |
| 2018-12-31 | $83.61M 20-F · filed 2019-03-26 |